Related Experiment Video
Updated: Aug 14, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Interfering with cancer: a brief outline of advances in RNA interference in oncology
1Axis Shield ASA, Ulvenveien 87, NO-0581 Oslo, Norway. phil.rye@no.axis-shield.com
Abstract:
RNA interference (RNAi) is a potent and ubiquitous gene-silencing mechanism that is generating considerable excitement in the fields of molecular biology and gene therapy. It is now in widespread use for loss-of-function analysis in many diseases including cancer. Nevertheless, RNAi is still in its infancy, with new discoveries appearing on a monthly basis. This article presents a brief outline of the history and recent advances in RNAi with a specific focus on its potential in oncology.
Insights
RNA interference (RNAi) is a powerful gene-silencing tool used in cancer research. Ongoing discoveries continue to advance its potential applications in oncology and gene therapy.
Area of Science:
- Molecular Biology
- Gene Therapy
- Oncology
Background:
- RNA interference (RNAi) is a natural gene-silencing mechanism.
- RNAi is widely utilized for loss-of-function studies in diseases like cancer.
- The field of RNAi is rapidly evolving with frequent new discoveries.
Purpose of the Study:
- To provide a historical overview of RNAi.
- To highlight recent advancements in RNAi technology.
- To focus on the therapeutic potential of RNAi in oncology.
Main Methods:
- Literature review of RNAi history and recent developments.
- Analysis of RNAi applications in cancer research.
- Exploration of future directions in RNAi-based oncology.
Main Results:
- RNAi has a significant history and ongoing rapid development.
- RNAi is a key tool for loss-of-function analysis in cancer.
- Emerging RNAi strategies show promise for cancer treatment.
Conclusions:
- RNAi is a fundamental tool in molecular biology with expanding therapeutic relevance.
- Continued research is crucial for realizing the full potential of RNAi in oncology.
- RNAi-based therapies represent a promising frontier in cancer treatment.
More Related Videos
11:57Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
Published on: April 21, 2016
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
MicroRNAs